Atef Halabi

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• Bayer (Germany)17.3%
• Boehringer Ingelheim (Germany)10.5%
• Inserm9.7%
• Actelion (Switzerland)9.3%
• University of Toronto6.5%
• Harvard University5.7%
• Other41.1%

Fields

• Medicine79.3%
• Biochemistry, Genetics and Molecular Biology11.5%
• Pharmacology, Toxicology and Pharmaceutics2.4%
• Immunology and Microbiology2%
• Nursing1.5%
• Chemistry1.2%
• Other2.2%

Topics

• Atrial Fibrillation Management and Outcomes19.1%
• Diabetes Treatment and Management12.9%
• Venous Thromboembolism Diagnosis and Management12.8%
• Chronic Kidney Disease and Diabetes9.3%
• Liver Disease and Transplantation5.8%
• Cardiac Arrhythmias and Treatments4.9%
• Other35.3%